Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription 04.03.2024 3 Blood 1 Br J Cancer 3 Br J Haematol 3 Leuk Lymphoma 1 Oncology (Williston Park) 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. BOARDMAN AP, Palomba ML
   Does BTKi improve CAR T-cell therapy in MCL?
   Blood. 2024;143:653-655.
   PubMed        
   
   
2. SCHUSTER SJ, Huw LY, Bolen CR, Maximov V, et al
   Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
   Blood. 2024;143:822-832.
   PubMed         Abstract available
   
   
3. FRIEDBERG JW, Bordoni R, Patel-Donnelly D, Larson T, et al
   Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy.
   Blood. 2024;143:786-795.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. LITTLE MP, Mai JZ, Fang M, Chernyavskiy P, et al
   Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
   Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
   PubMed         Abstract available
   
   

   
   Br J Haematol

5. BISHTON MJ, Crooks CJ, Card TR, West J, et al
   Ethnicity and socio-economic status affects the incidence and survival of hepatosplenic T-cell lymphoma.
   Br J Haematol. 2024 Feb 29. doi: 10.1111/bjh.19371.
   PubMed         Abstract available
   
   
6. YE P, Cheng Y, Lian J, Tong H, et al
   Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study.
   Br J Haematol. 2024 Feb 23. doi: 10.1111/bjh.19367.
   PubMed         Abstract available
   
   
7. STEPANISHYNA Y, Manni M, Civallero M, Shokun N, et al
   Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021.
   Br J Haematol. 2024 Feb 23. doi: 10.1111/bjh.19352.
   PubMed         Abstract available
   
   

   
   Leuk Lymphoma

8. MINSON A, Dickinson M
   Combining forces for good: chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement.
   Leuk Lymphoma. 2024 Feb 29:1-2. doi: 10.1080/10428194.2024.2320833.
   PubMed        
   
   
9. ATTYGALLE AD, Chan JKC, Coupland SE, Du MQ, et al
   The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.
   Leuk Lymphoma. 2024;65:413-429.
   PubMed         Abstract available
   
   
10. ATALLAH-YUNES SA, Khurana A, Maurer M
    Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials.
    Leuk Lymphoma. 2024;65:430-439.
    PubMed         Abstract available
    
    

    
    Oncology (Williston Park)

11. LYMPHOMA RESEARCH FOUNDATION L
    Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma.
    Oncology (Williston Park). 2024;38:51-67.
    PubMed         Abstract available
    
    

    
    PLoS One

12. SARPA M, da Costa VIDB, Ferreira SN, de Almeida CA, et al
    Investigation of occupational risk factors for the development of non-Hodgkin's lymphoma in adults: A hospital-based case-control study.
    PLoS One. 2024;19:e0297140.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.